Toward High-Throughput Drug Screening Using Mass Spectrometry
The DOI matches its Crossref record.
Abstract
A critical overview on the potential of mass spectrometry-based methods regarding high-throughput screening analysis is presented. Within this scope, screening procedures will be discussed for simultaneous detection of several drug classes relevant to clinical and forensic toxicology or doping control in urine or blood using gas chromatography-mass spectrometry or liquid chromatography-mass spectrometry.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Metabolomics technology and bioinformatics
Shulaev, V. (2006) · Briefings in Bioinformatics · doi:10.1093/bib/bbl012 · Cited by 408
Reed, T., Perluigi, M., Sultana, R., Pierce, W. M., Klein, J. B., Turner, D. M., Coccia, R., Markesbery, W. R., & Butterfield, D. A. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.12.007 · Cited by 257
“Amnestic MCI patients met the criteria described by Petersen (Petersen, 2003) which included: a memory complaint supported by an informant, objective memory test impairment (age-and education-adjusted), general normal global intellectual function, intact ADLs, Clinical Dementia Rating score of 0.0 to 0.5, no dementia,…”
InfluentialCurrent role of liquid chromatography–mass spectrometry in clinical and forensic toxicology
Maurer, H. H. (2007) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-007-1248-5 · Cited by 257
Self-citationPerluigi, M., Sultana, R., Cenini, G., Di Domenico, F., Memo, M., Pierce, W. M., Coccia, R., & Butterfield, D. A. (2009) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200800161 · Cited by 196
“[20] Maurer, H. H., Peters, F. T., Toward high-throughput drug screening using mass spectrometry.”
InfluentialReed, T. T., Pierce Jr., W. M., Turner, D. M., Markesbery, W. R., & Allan Butterfield, D. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00478.x · Cited by 135
Metadata
- Authors
- Maurer, H. H., & Peters, F. T.
- Venue
- Therapeutic Drug Monitoring
- Published
- 2005-12
- Volume
- 27
- Issue
- 6
- Pages
- 686-688
- ISSN
- 0163-4356 (ISSN-L)
- OpenAlex
- W2092360080
- Cited by
- 47
- References
- 0
- FWCI
- 7.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Toward High-Throughput Drug Screening Using Mass Spectrometry. https://app.cochat.ai/papers/10.1097/01.ftd.0000180224.19384.f0
- The paper
- Maurer, H. H., & Peters, F. T. (2005). Toward High-Throughput Drug Screening Using Mass Spectrometry. Therapeutic Drug Monitoring. https://doi.org/10.1097/01.ftd.0000180224.19384.f0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.